BioSpace News Archive

Polarean (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced MRI scanning of the lungs, announces it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company’s specialized MRI chest coil to now include Philips 3.0T MRI scanners for the visualization of the Xenon-129 (129Xe) nuclei.

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces its financial results for the second quarter ended June 30, 2023, and provides a corporate update.

Complement Therapeutics GmbH, a preclinical stage biotechnology company developing novel therapeutics for complement-mediated diseases, announced the appointment of Dr Parisa Zamiri as its Chief Medical Officer, effective immediately.

Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, reported its financial results for the second quarter ended June 30, 2023 and provided a business update.

Global health company The Cigna Group reported strong second quarter 2023 results reflecting growth and focused execution across our diversified portfolio of businesses.

Affimed N.V. announced that it will release second quarter 2023 results and corporate update on Thursday, August 10, 2023.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for rare diseases, reported business highlights and financial results for the second quarter ended June 30, 2023.

Regeneron Pharmaceuticals, Inc. announced financial results for the second quarter of 2023 and provided a business update.

InfuSystem Holdings, Inc., a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, reported financial results for the second quarter ended June 30, 2023.

Fulcrum Therapeutics, Inc.®, a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, reported financial results for the second quarter of 2023 and provided a business update.